ORAMED PHARMACEUTICALS INC. (ORMP.OB) is a publicly traded company in the Unknown sector. Across all available filings, 2 corporate insiders have executed 6 transactions totaling $746.0K, demonstrating a bullish sentiment with $354.0K in net insider flow. The most recent transaction on Nov 2, 2012 involved a transaction of 135,135 shares valued at $36.5K.
No significant insider buying has been recorded for ORMP.OB in the recent period.
No significant insider selling has been recorded for ORMP.OB in the recent period.
Based on recent SEC filings, insider sentiment for ORMP.OB is bullish with an Insider Alignment Score of 74/100 and a net flow of $354.0K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at ORAMED PHARMACEUTICALS INC. (ORMP.OB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 2 insiders are actively trading ORMP.OB stock, having executed 6 transactions in the past 90 days. The most active insider is Zeev Bronfeld (Executive), who has made 3 transactions totaling $446.0K.
Get notified when executives and directors at ORMP.OB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 2, 2012 | Sank Leonard | Executive | Award | 135,135 | $0.27 | $36.5K | |
| Aug 22, 2012 | Sank Leonard | Executive | Award | 270,270 | $0.27 | $73.0K | |
| Oct 4, 2011 | Sank Leonard | Executive | Purchase | 937,500 | $0.32 | $300.0K | |
| Sep 27, 2011 | Bronfeld Zeev | Executive | Sale | 350,000 | $0.28 | $98.0K | |
| Sep 27, 2011 | Bronfeld Zeev | Executive | Sale | 350,000 | $0.28 | $98.0K | |
| Mar 31, 2011 | Bronfeld Zeev | Executive | Purchase | 781,250 | $0.32 | $250.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 2 | $550.0K | 64.3% |
Sale(S) | 2 | $196.0K | 22.9% |
Award(A) | 2 | $109.5K | 12.8% |
Insiders at ORAMED PHARMACEUTICALS INC. are accumulating shares at an accelerated pace. With 2 insiders making 6 transactions totaling $550.0K in purchases versus $196.0K in sales, the net buying activity of $354.0K signals strong executive confidence. Zeev Bronfeld (Executive) leads the buying activity with $446.0K in transactions across all time.